statistiche ricercatore

CAMPIOTTI, LEONARDO

Distribuzione geografica

Continente	#
NA - Nord America	7.934
EU - Europa	3.778
AS - Asia	2.348
SA - Sud America	366
Continente sconosciuto - Info sul continente non disponibili	169
AF - Africa	48
OC - Oceania	4
Totale	14.647

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	7.782
IT - Italia	1.969
SG - Singapore	848
CN - Cina	513
UA - Ucraina	404
VN - Vietnam	377
SE - Svezia	321
BR - Brasile	298
DE - Germania	269
HK - Hong Kong	259
FR - Francia	184
IE - Irlanda	142
TR - Turchia	141
GB - Regno Unito	135
RU - Federazione Russa	90
FI - Finlandia	69
CA - Canada	56
IN - India	56
NL - Olanda	56
MX - Messico	53
BD - Bangladesh	49
ES - Italia	29
AR - Argentina	24
PL - Polonia	23
JP - Giappone	22
AT - Austria	19
BE - Belgio	19
ZA - Sudafrica	16
EC - Ecuador	14
IQ - Iraq	12
CR - Costa Rica	11
NG - Nigeria	10
SA - Arabia Saudita	9
LT - Lituania	8
MD - Moldavia	8
PE - Perù	7
PK - Pakistan	7
VE - Venezuela	7
CL - Cile	6
CO - Colombia	6
ID - Indonesia	6
JO - Giordania	6
MA - Marocco	6
HN - Honduras	5
IL - Israele	5
JM - Giamaica	5
PT - Portogallo	5
SV - El Salvador	5
UZ - Uzbekistan	5
AE - Emirati Arabi Uniti	4
EU - Europa	4
KE - Kenya	4
PH - Filippine	4
AI - Anguilla	3
AU - Australia	3
BO - Bolivia	3
CH - Svizzera	3
DK - Danimarca	3
DZ - Algeria	3
GR - Grecia	3
KZ - Kazakistan	3
MK - Macedonia	3
MY - Malesia	3
NI - Nicaragua	3
QA - Qatar	3
RO - Romania	3
TT - Trinidad e Tobago	3
AM - Armenia	2
AZ - Azerbaigian	2
BG - Bulgaria	2
CW - ???statistics.table.value.countryCode.CW???	2
CZ - Repubblica Ceca	2
EG - Egitto	2
ET - Etiopia	2
GP - Guadalupe	2
GT - Guatemala	2
HU - Ungheria	2
IR - Iran	2
LK - Sri Lanka	2
RS - Serbia	2
SC - Seychelles	2
TH - Thailandia	2
TN - Tunisia	2
AG - Antigua e Barbuda	1
BA - Bosnia-Erzegovina	1
BY - Bielorussia	1
CY - Cipro	1
GD - Grenada	1
KN - Saint Kitts e Nevis	1
LB - Libano	1
LU - Lussemburgo	1
ME - Montenegro	1
MN - Mongolia	1
NO - Norvegia	1
NP - Nepal	1
NR - Nauru	1
PR - Porto Rico	1
PS - Palestinian Territory	1
PY - Paraguay	1
SN - Senegal	1
Totale	14.483

Salva come PNG Salva come JPEG

Città	#
Milan	1.067
Ashburn	886
Fairfield	816
San Jose	650
Singapore	471
Chandler	440
Woodbridge	414
Houston	346
Seattle	327
Jacksonville	320
Wilmington	319
Cambridge	260
Hong Kong	256
Council Bluffs	228
Dallas	218
Ann Arbor	210
Dearborn	180
Nyköping	178
Beijing	163
Princeton	157
Dublin	141
New York	120
Como	109
Boardman	103
Rome	88
Dong Ket	85
The Dalles	82
Ho Chi Minh City	78
Chicago	75
Lauterbourg	75
Santa Clara	61
Izmir	59
Los Angeles	59
San Diego	59
Munich	50
Kocaeli	44
Hanoi	41
Mexico City	40
São Paulo	38
Redmond	37
Orem	36
Frankfurt am Main	33
London	33
Ogden	31
Helsinki	26
San Mateo	25
Chennai	22
Brooklyn	21
Tokyo	20
Brussels	17
Buffalo	17
Phoenix	17
Atlanta	16
Manchester	16
Toronto	16
Warsaw	16
Guangzhou	15
Denver	14
Kunming	14
Montreal	14
Nuremberg	14
Amsterdam	13
Boston	13
Johannesburg	13
Naples	13
Cavaria con Premezzo	12
Hefei	12
Redwood City	12
Stockholm	12
Bologna	11
Haiphong	11
Mumbai	11
Nanjing	11
Norwalk	11
San Francisco	11
Washington	11
Abuja	10
Genoa	10
Turku	10
Belo Horizonte	9
Falkenstein	9
Rio de Janeiro	9
Shanghai	9
Varese	9
Da Nang	8
Philadelphia	8
San José	8
Turin	8
Vienna	8
Hangzhou	7
New Delhi	7
Verona	7
Ankara	6
Berlin	6
Catania	6
Dhaka	6
Falls Church	6
Florence	6
Guayaquil	6
Las Vegas	6
Totale	10.144

Salva come PNG Salva come JPEG

Nome	#
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	428
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)	303
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	279
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	256
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	250
Right ventricular remodelling in mild hypertensive patients: role of left ventricular morpho-functional parameters	231
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis	224
Assessing residual disease in imatinib-treated CML patients by DNA compared to MRNA assays	222
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML	218
Acute myeloid leukemia with associated translocation t(15;17) and 11q23/MLL abnormality	216
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—comment	214
A particular case of AML patient with the polymorphism G105G (rs11554137) and the missense mutation R132C in IDH1 gene	214
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia	209
JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential	209
Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases	208
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia	204
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register	203
Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06	203
In vitro effects of Apixaban on 5 different cancer cell lines	201
Fatal Splenic Rupture in a Previously Undiagnosed Multiple Myeloma: Morphological, Immunophenotypical and Molecular Cytogenetic Analyses	200
sRAGE and early signs of cardiac target organ damage in mild hypertensives	200
Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis	199
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub	197
JAK2 mutation and atypical chronic myeloid leukemia	195
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients	194
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	194
JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia.	193
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia	190
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study).	189
Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia	185
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR)	183
Tirosine kinase inhibitors adverse events	182
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register	181
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia	173
Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-centre experience	167
IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG)	167
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards	166
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people	166
Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia	160
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study	159
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry	159
What changed in the Italian internal medicine and geriatric wards during the lockdown	159
Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study)	155
Primary non-Hodgkin's lymphoma of the kidney: A case report	155
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients	154
Metabolic tumour volume and response to therapy in diffuse large B cell lymphoma	154
Clinical features, treatment and outcome of patients with low-grade gastric MALT lymphoma: a single centre experience	153
Molecular monitoring of residual disease in chronic myeloid leukemia by genomic DNA compared with conventional mRNA analysis.	149
Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells	148
Pain and Frailty in Hospitalized Older Adults	147
Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis	144
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients	143
Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study	143
Primary testicular non-Hodgkin lymphomas. A clinicopathologic study of nine cases	141
NEXT GENERATION SEQUENCING (NGS) CONFIRMED THE ADVERSE CLINICAL IMPACT OF RUNX1 MUTATIONS IN A SUBSET OF ACUTE MYELOID LEUKEMIA NORMAL KARYOTYPE PATIENTS NEGATIVE FOR RISK DEFINING GENES MUTATIONS AND HOMOGENOUSLY TREATED WITHIN A CLINICAL TRIAL (NILG AML 02/06)	141
Tyrosin-Kinase Inhibitors Discontinuation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis	138
MOLECULAR PROLIFE BY NEXT GENERATION SEQUENCING OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE: CLINICAL RESULTS FROM THE PROSPECTIVE TRIAL 02/06 OF THE NORTHERN ITALY LEUKEMIA GROUP (NILG)	136
Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06	135
Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study	134
Antibiotic use and associated factors in a large sample of hospitalised older people	133
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06	132
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry	132
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia	129
Composite follicular lymphoma and “early” (in situ and mantle zone growth pattern) mantle cell neoplasia: A rare entity with peculiar cytogenetic and clinical features	127
CEOP 1-8 regimen for treatment of intermediate-high grade non-Hodgkin's lymphoma in elderly patients	126
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients	126
Evaluation of international prognostic factors project for patients with advanced Hodgkin's disease: A single centre experience	124
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)	124
TWO-STEP RESPONSE-ORIENTED INDUCTION PREDICTS LONG-TERM OUTCOME OF ADULT PATIENTS WITH STANDARD- AND HIGH-RISK ACUTE MYELOID LEUKAEMIA (AML): A NORTHERN ITALY LEUKAEMIA GROUP (NILG) STUDY	122
Subacute demyelinating polyneuropathy associated with B-cell lymphoma and IgM antibodies against myelin-associated glycoprotein responsive to rituximab	119
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry	119
Association of hairy cell leucemia (HCL) with low-grade non Hodgkin lymphoma (NHL) successfully treated with retuximab. A case report	118
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)	115
Primary gastric lymphomas. Clinico-pathological study and evaluation of prognostic factors in 65 cases treated surgically	110
CLINICAL SIGNIFICANCE OF END OF INDUCTION MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION AFTER A SINGLE CHEMOTHERAPY COURSE	110
PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE	110
Association of ARA-C, mitoxantrone and etoposide in elderly affected by acute myeloid leucemia	109
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients	98
Post-Treatment Residual Disease Detection by Droplet Digital PCR in Hairy Cell Leukemia: Comparison with Allele Specific PCR and Immunohistochemistry	95
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study	91
High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy	90
Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer	89
Low efficacy of thalidomide in improving response after induction in myeloma patients candidate to high-dose therapy	89
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register	86
Multicentric castleman disease with splenic presentation: report of two rare cases with focus on histopathological features and review of the literature	83
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register	83
Integrated genomic, functional, and prognostic characterization of atypical chronic myeloid leukemia	77
BCL2 in follicular lymphomas (FL): the overrated guy?	77
Correction to: Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta‑analysis (Internal and Emergency Medicine, (2023), 18, 2, (535-547), 10.1007/s11739-023-03208-9)	75
A case of multicentric Castleman's disease mimicking non-Hodgkin lymphoma: when splenectomy is diagnostic and therapeutic	72
Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta-analysis	71
Impact of vitamin D plasma levels on in vitro natural killer cell cytotoxicity against non-small cell lung carcinoma in the presence of nivolumab	55
Idiopathic splanchnic vein thrombosis unmasking a clonal autoinflammatory disease	43
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry	26
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry	24
Clinically recognized sepsis in older adults admitted to medical wards: patient characteristics and hospital outcomes from the REPOSI register	18
Totale	14.647

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	64.333
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	64.333

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	643	0	0	0	55	35	106	33	30	53	171	64	96
2022/2023	1.253	130	86	90	128	101	234	1	189	186	37	36	35
2023/2024	1.724	263	260	244	319	303	159	16	27	62	30	17	24
2024/2025	1.369	25	25	252	40	55	75	63	95	148	122	122	347
2025/2026	3.652	294	250	236	504	337	234	644	199	382	248	208	116
2026/2027	1.186	89	191	456	450	0	0	0	0	0	0	0	0
Totale													14.647